LBRX · Lb Pharmaceuticals Inc · Investor Relations
$39.70
-0.45 (-1.12%)
At close · Oct 30
Return incl. dividend (before tax)
Market Cap
$1.28B
Shares
32.26M
Volume · Oct 30
429.48K
Avg daily vol (3M)
367.84K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Upcoming events
| Date | Event | Type |
|---|---|---|
| 2026-11-09 00:00 UTC | Guggenheim 3rd Annual Healthcare Innovation Conference | Conference |
| 2026-11-12 00:00 UTC | Stifel 2026 Healthcare Conference | Conference |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-10-27 | LB Pharma R&D Day: Advancing LB‑102 with a Focus on Schizophrenia Treatment | Webcast |
| 2026-09-23 | TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit | Webcast |
| 2026-09-14 | H.C. Wainwright 28th Annual Global Investment Conference | Conference |
| 2026-06-16 | H.C. Wainwright 7th Annual Neuro Perspectives Hybrid Conference | Conference |
| 2026-06-04 | Jefferies Global Healthcare Conference | Conference |
Source: https://ir.lbpharma.us/
Key facts
CIK
1691082
CUSIP
50180M108
13F (30d)
19 filings
19 filers
Visit website
Investor relations